Location
Moultrie, GA
Start Date
17-4-2026 12:00 PM
End Date
17-4-2026 1:00 PM
Description
Introduction: Doxycycline is a tetracycline-class antibiotic that inhibits bacterial protein synthesis by binding to the 30s ribosomal subunit, thereby preventing bacterial growth. It has a broad spectrum of clinical indications including treatment of Chlamydia infections, Lyme disease, Anthrax, Rickettsia, Atypical pneumonia, Staph aureus, Cholera, Acne vulgaris, and Traveler’s diarrhea, as well as malarial prophylaxis. Although generally well tolerated, effective and affordable, doxycycline is associated with several mild adverse effects like gastrointestinal distress and photosensitivity. One clinically significant adverse reaction is phototoxicity which occurs following exposure to ultraviolet radiation. In doxycycline-induced phototoxicity, the drug absorbs UV light and generates reactive oxygen species (ROS), leading to direct cellular damage in the skin cells. This process results in inflammation and manifests clinically as erythema, burning sensations, edema or blistering in sun-exposed areas.
Methods: A narrative literature review was conducted to evaluate the pathophysiology, clinical presentation, and prevention of doxycycline-induced phototoxicity. Peer reviewed articles were identified through databases such as PubMed and other biomedical databases. Relevant clinical guidelines and pharmacologic data were reviewed from authoritative sources, including CDC, NIH, FDA, Medscape, UpToDate, WHO and Epilepsy Foundation websites. Abstracts were screened for relevance, followed by full-text review of selected articles focused on mechanisms of phototoxicity, clinical manifestations, and prevention strategies.
Results: Doxycycline absorbs ultraviolet-A (UVA) radiation in the 320 to 400 nm wavelength range. Upon absorption, the drug becomes photoactivated and transitions into an excited molecular state leading to the formation of reactive oxygen species. This induces oxidative stress by causing lipid peroxidation of cellular membrane, fragments DNA, and triggers keratinocyte apoptosis. The resulting cellular injury manifests clinically as burning sensation, erythema, edema, blistering, and desquamation in localized skin. Doxycycline is widely prescribed, placing a substantial patient population at risk for phototoxic reactions. Doxycycline-induced phototoxicity (DIP) is frequently misdiagnosed as sunburn or allergic contact dermatitis, resulting in delayed recognition. Delayed diagnosis may lead to prolonged symptoms and preventable skin injury. Pre-treatment patient counseling and anticipatory sun-protection strategies significantly reduce incidence and severity of reactions.
Discussion: DIP is characterized by rapid-onset, exaggerated sunburn-like reactions that may occasionally present in a delayed fashion following UV exposure. Clinical manifestations are typically confined to sun-exposed areas. Prevention remains the most effective strategy. Patients should be counseled to avoid direct sun exposure, particularly during peak UV hours and to avoid tanning beds. Photoprotective measures include daily use of broad-spectrum sunscreen, protective clothing and sunglasses. If moderate to severe phototoxicity occurs, immediate discontinuation of doxycycline is recommended. Supportive care includes cool compresses to reduce inflammation and discomfort. Proactive patient education prior to prescribing doxycycline significantly reduces preventable morbidity.
Embargo Period
5-28-2026
Included in
Understanding Doxycycline-Induced Phototoxicity
Moultrie, GA
Introduction: Doxycycline is a tetracycline-class antibiotic that inhibits bacterial protein synthesis by binding to the 30s ribosomal subunit, thereby preventing bacterial growth. It has a broad spectrum of clinical indications including treatment of Chlamydia infections, Lyme disease, Anthrax, Rickettsia, Atypical pneumonia, Staph aureus, Cholera, Acne vulgaris, and Traveler’s diarrhea, as well as malarial prophylaxis. Although generally well tolerated, effective and affordable, doxycycline is associated with several mild adverse effects like gastrointestinal distress and photosensitivity. One clinically significant adverse reaction is phototoxicity which occurs following exposure to ultraviolet radiation. In doxycycline-induced phototoxicity, the drug absorbs UV light and generates reactive oxygen species (ROS), leading to direct cellular damage in the skin cells. This process results in inflammation and manifests clinically as erythema, burning sensations, edema or blistering in sun-exposed areas.
Methods: A narrative literature review was conducted to evaluate the pathophysiology, clinical presentation, and prevention of doxycycline-induced phototoxicity. Peer reviewed articles were identified through databases such as PubMed and other biomedical databases. Relevant clinical guidelines and pharmacologic data were reviewed from authoritative sources, including CDC, NIH, FDA, Medscape, UpToDate, WHO and Epilepsy Foundation websites. Abstracts were screened for relevance, followed by full-text review of selected articles focused on mechanisms of phototoxicity, clinical manifestations, and prevention strategies.
Results: Doxycycline absorbs ultraviolet-A (UVA) radiation in the 320 to 400 nm wavelength range. Upon absorption, the drug becomes photoactivated and transitions into an excited molecular state leading to the formation of reactive oxygen species. This induces oxidative stress by causing lipid peroxidation of cellular membrane, fragments DNA, and triggers keratinocyte apoptosis. The resulting cellular injury manifests clinically as burning sensation, erythema, edema, blistering, and desquamation in localized skin. Doxycycline is widely prescribed, placing a substantial patient population at risk for phototoxic reactions. Doxycycline-induced phototoxicity (DIP) is frequently misdiagnosed as sunburn or allergic contact dermatitis, resulting in delayed recognition. Delayed diagnosis may lead to prolonged symptoms and preventable skin injury. Pre-treatment patient counseling and anticipatory sun-protection strategies significantly reduce incidence and severity of reactions.
Discussion: DIP is characterized by rapid-onset, exaggerated sunburn-like reactions that may occasionally present in a delayed fashion following UV exposure. Clinical manifestations are typically confined to sun-exposed areas. Prevention remains the most effective strategy. Patients should be counseled to avoid direct sun exposure, particularly during peak UV hours and to avoid tanning beds. Photoprotective measures include daily use of broad-spectrum sunscreen, protective clothing and sunglasses. If moderate to severe phototoxicity occurs, immediate discontinuation of doxycycline is recommended. Supportive care includes cool compresses to reduce inflammation and discomfort. Proactive patient education prior to prescribing doxycycline significantly reduces preventable morbidity.